[1]
I. . Fediak and T. Volosheniuk, “Marketing study of selective serotonin reuptake inhibitors for the treatment of post-traumatic stress disorder in military servants and war veterans”, ScienceRise: Pharmaceutical Science, no. 6(52), pp. 90–102, Dec. 2024.